Merck KGaA has announced an $11.3 billion agreement to acquire U.S.-based Bio-Techne, marking the German pharmaceutical giant’s largest acquisition since 2014. The deal, which offers $73 per share—a 24% premium over the closing price on Wednesday—is designed to bolster Merck’s life sciences division by integrating Bio-Techne’s extensive portfolio of research reagents, proteins, and analytical instruments … Read more
The Ebola Bundibugyo outbreak in the Democratic Republic of Congo has reached over 1,100 confirmed cases and nearly 300 deaths, according to government reports. Health officials, including the World Health Organization (WHO), state that a lack of diagnostic tools, limited clinical data, and community mistrust regarding the virus’s atypical symptoms are currently hindering containment efforts … Read more
The U.S. government has begun shipping stockpiled doses of an experimental antibody drug, MBP134, from Mapp Biopharmaceutical to the Democratic Republic of Congo to combat a widening Bundibugyo Ebola outbreak. According to the U.S. Department of Health and Human Services, this shift in policy marks the first time Washington has released the treatment for clinical … Read more
Why Patient Access to New Medicines is Worsening Across Europe Patient access to new medicines in Europe is deteriorating, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), which released research highlighting a 597-day average delay between drug approval and patient availability—up from 504 days in 2019. The study, conducted by Germany’s WifOR … Read more
Australian authorities are investigating the country’s first suspected mainland case of H5N1 avian influenza after a brown skua found in Western Australia’s Cape Le Grand National Park tested positive for the virus. State Agriculture Minister Jackie Jarvis confirmed that further testing is underway to verify the strain, with results expected shortly. While Australia remains the … Read more
The Lincoln Memorial Reflecting Pool’s newly renovated floor has begun peeling less than two weeks after the project’s completion, according to reports from June 18, 2026. The $14.7 million no-bid renovation, ordered by President Donald Trump to paint the pool blue, is currently marred by flaking paint and an algae bloom that has turned the … Read more
Nvidia is raising $25 billion through a massive U.S. bond issuance, marking the chipmaker’s first return to the debt market since 2021. According to reports from Reuters, the company expanded the offering beyond its initial $20 billion target due to $85 billion in investor demand. The capital, managed by bookrunners Goldman Sachs, J.P. Morgan, and … Read more
A Chinese-linked hacking group, identified by Google as UNC6508, exfiltrated sensitive data from U.S. and Canadian research institutions for over a year by exploiting vulnerabilities in REDCap software. According to Google’s Threat Intelligence Group, the campaign targeted defense, artificial intelligence, and medical research data between September 2023 and November 2025. The operation utilized custom malware … Read more
Distrust and civil unrest are severely hampering Ebola contact tracing in displacement camps across the Democratic Republic of Congo. According to Dr. Jean-Claude Lonzama, chief doctor for the Nizi health zone, health workers are unable to monitor potential transmission chains because local residents, skeptical of the virus’s existence, have blocked aid teams from entering sites … Read more
Anthropic has disabled its advanced AI models, Fable 5 and Mythos 5, on a global scale following U.S. national security orders. The Trump administration mandated the shutdown after officials identified a “jailbreak” vulnerability that could allow users to leverage the technology for identifying cybersecurity flaws. While Anthropic maintains the risks are minor, the move marks … Read more